Sign in

CIK 0001497253

  • Non-accelerated filer
  • Smaller reporting company

VivoSim Labs, INC.

Sign in to watch
Ticker
VIVS
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Mar 31
Incorporated
DE
Entity type
Operating
EIN
271488943
Phone
+1 858-224-1000
Business address
11555 SORRENTO VALLEY ROAD, SUITE 100, SAN DIEGO, CA, 92121
Former names
ORGANOVO HOLDINGS, INC., REAL ESTATE RESTORATION & RENTAL, INC.
  1. 4 Shares withheld for taxes CSO & EVP Pre-Clinical Dev gave up 1,205 shares (to pay taxes)
  2. 4 Shares withheld for taxes General Counsel & Secretary gave up 1,214 shares (to pay taxes)
  3. 3 Insider Initial Statement of Ownership
  4. 4 Grant or award Director acquired 15,000 shares (grant or award)
  5. 4 Grant or award Director acquired 7,500 shares (grant or award)
  6. 4 Grant or award Director acquired 15,000 shares (grant or award)
  7. 4 Grant or award Director acquired 7,500 shares (grant or award)
  8. 4 Grant or award Director acquired 7,500 shares (grant or award)
  9. 4 Grant or award Director acquired 7,500 shares (grant or award)
  10. 3 Insider Initial Statement of Ownership
  11. 3 Insider Initial Statement of Ownership
  12. 4 Open-market sale CSO & EVP Pre-Clinical Dev sold 20,000 shares at $4.55 ($91,000)
  13. 4 Grant or award Chief Scientific Officer acquired 50,000 shares (grant or award)
  14. 4 Grant or award Chairman, CEO and President acquired 208,000 shares (grant or award)
  15. 4 Grant or award General Manager acquired 47,500 shares (grant or award)
  16. 4 Grant or award CSO & EVP Pre-Clinical Dev acquired 50,000 shares (grant or award)
  17. 4 Grant or award General Counsel & Secretary acquired 50,000 shares (grant or award)
  18. 5 Insider Annual Insider Trading Report
  19. 5 Insider Annual Insider Trading Report
  20. 4 Shares withheld for taxes Chairman, CEO and President gave up 24,690 shares (to pay taxes)

Page 10 of 16 · 306 filings